Home
Lupin Limited
Press Release May 26 2025
Business
May 27 2025
3 min read

Press Release May 26 2025

Lupin Limited has informed the Exchange regarding a press release dated May 26, 2025, titled "Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at theAmerican Society of Clinical Oncology - Annual Meeting 2025".

View Attachment